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Abstract
Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of updating the guidelines
on the diagnosis and management of food allergy. The existing guidelines are based on a systematic review of the literature until
30th September 2012. Therefore, a new systematic review must be undertaken to inform the new guidelines. This systematic
review aims to assess the accuracy of index tests to support the diagnosis of IgE-mediated food allergy. Methods: The databases
Cochrane CENTRAL (Trials), MEDLINE (OVID) and Embase (OVID) will be searched for diagnostic test accuracy studies
from 1st October 2012 to 30th June 2021. Inclusion and exclusion criteria will be used to select appropriate studies. Data from
these studies will be extracted and tabulated, and then reviewed for risk of bias and applicability using the QUADAS-2 tool.
All evaluation will be done in duplicate. Studies with a high risk of bias and low applicability will be excluded. Meta-analysis
will be performed if there are three or more studies of the same index test and food. Results: A protocol for the systematic
review and meta-analyses is presented and was registered using Prospero prior to commencing the literature search. Discussion:
Oral food challenges are the reference standard for diagnosis but involve considerable risks and resources. This protocol for
systematic review aims to assess the accuracy of various tests to diagnose food allergy, which can be useful in both clinical and
research settings.
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Background: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of
updating the guidelines on the diagnosis and management of food allergy. The existing guidelines are based
on a systematic review of the literature until 30th September 2012. Therefore, a new systematic review must
be undertaken to inform the new guidelines. This systematic review aims to assess the accuracy of index
tests to support the diagnosis of IgE-mediated food allergy.
Methods: The databases Cochrane CENTRAL (Trials), MEDLINE (OVID) and Embase (OVID) will be
searched for diagnostic test accuracy studies from 1st October 2012 to 30th June 2021. Inclusion and exclusion
criteria will be used to select appropriate studies. Data from these studies will be extracted and tabulated,
and then reviewed for risk of bias and applicability using the QUADAS-2 tool. All evaluation will be done
in duplicate. Studies with a high risk of bias and low applicability will be excluded. Meta-analysis will be
performed if there are three or more studies of the same index test and food.
Results: A protocol for the systematic review and meta-analyses is presented and was registered using
Prospero prior to commencing the literature search.
Discussion: Oral food challenges are the reference standard for diagnosis but involve considerable risks and
resources. This protocol for systematic review aims to assess the accuracy of various tests to diagnose food
allergy, which can be useful in both clinical and research settings.
Keywords: Food allergy, IgE-mediated, diagnosis, diagnostic tests, specific IgE, skin prick test, component-
resolved diagnostics, basophil activation test, mast cell activation test
Key message: This is the protocol for the systematic review of the literature which will inform the update
of the Food Allergy Guidelines of the European Academy of Allergy and Clinical Immunology (EAACI).
Background
The global prevalence of food allergy is about 10% with an increase in its incidence in the last 20-30 years1,2.
Evidence suggests that allergies to food are more common in Westernized countries, affecting children more
than adults3. Any food can be a potential allergen; however, a large proportion of food allergies worldwide
can be accounted for by nuts, milk, eggs, shellfish and wheat4. Different foods act as the most common
allergens in different countries; while peanut allergies are relatively common in the UK, USA, Canada and
Australia, they are very rarely seen in Asia, excluding Japan. Overall, milk and eggs appear to be the most
common allergens in young children in the UK and most parts of Europe, USA, Canada, Asia and Australia5.
Food allergies can be classified as immunoglobulin E (IgE) mediated and non-IgE mediated, with the former
being the most common and the focus of this systematic review. IgE mediated food allergies usually induce
immediate reactions, i.e. reactions that occur up to 2 hours (usually a few minutes) after exposure to the
allergen, and these can be severe, and sometimes life threatening. By contrast, non-IgE mediated allergies
prompt a delayed response, with symptoms taking up to two days to evolve, or manifest chronically6. Clinical
manifestations of food allergy include skin, gastrointestinal (GI) and respiratory reactions, with skin reactions
being the most prevalent and presenting as urticaria, angioedema and erythema4,7. GI symptoms include
abdominal pain, diarrhoea, nausea and vomiting. Rhinorrhoea, nasal obstruction, bronchospasms and oedema
of the larynx are possible respiratory symptoms2. Allergic reactions can vary in severity, ranging from local
reactions such as tingling in the mouth to anaphylaxis, a severe life-threatening allergic reaction affecting
breathing or circulation4,8.
The diagnosis of IgE-mediated food allergy is usually based on the clinical presentation and evidence of IgE
sensitisation to the specific allergen, as documented by a positive skin prick test (SPT) or serum specific IgE9.
The reference standard is the oral food challenge (OFC), in which the suspected allergen is administered
orally in gradually increasing doses until either a reaction occurs or all doses are tolerated. OFC are resource
intensive as they must be conducted in a medical setting due to the risk of anaphylaxis. The results can
subsequently be used to confirm the diagnosis, to assess tolerability in people with a confirmed allergy, or to
detect the reaction threshold. In cases with a recent history of an allergic reaction, detectable IgE specific


























































































































Several tests have been suggested as alternatives for OFC. While SPT and sIgE confirm presence of IgE
antibodies to a particular food (sensitisation) they do not necessarily correlate to a clinical reaction, with
approximately half of children sensitised able to tolerate the food without reaction. These routine tests
therefore generally have high sensitivity but poor specificity to clinical food allergy. Increasing magnitude of
these tests are associated with increased risk of clinical reaction, and thresholds with high probability of food
allergy have been identified for some foods (e.g. for peanut: SPT >=8mm or sIgE >=15 have 95%PPV)
which negate the need for OFC in some settings. Reported thresholds vary in the literature, likely due
to differences in study design and patient characteristics. Component-resolved diagnosis (CRD) refers to
the determination of specific IgE levels to specific proteins in food10. Additional tests include the basophil
activation test (BAT) and the mast cell activation test (MAT); however these are currently not used in
routine clinical settings. CRD, BAT and MAT are emerging tests with early studies suggesting that they
offer an improvement on sensitivity and specificity than traditional SPT or sIgE tests.
The European Academy of Allergy and Clinical Immunology is currently in the process of updating their
food allergy guidelines. Thus, a systematic review of existing literature will be carried out to inform the new
guidelines. The systematic review aims to assess the diagnostic accuracy measured by sensitivity and speci-
ficity of index tests for IgE-mediated food allergy compared to the standard OFC. Furthermore, comparison
among index tests will be conducted if sufficient evidence is available.
Methods
Search strategy
The following databases will be searched:
• Cochrane CENTRAL (Trials)
• MEDLINE (OVID)
• Embase (OVID)
These databases will be searched for entries between the period of 1st October 2012 to the 31st May 2021.
This aligns with the end date of the search entries used in a previous systematic review on the same subject11.
Studies which were published earlier and included in the previous systematic review will be evaluated for
inclusion in the current systematic review.
Forward and backward citation analysis will be used in all included studies to pinpoint other relevant studies.
Any additional studies discovered by the review team who are experts in the field may be included. Only
published, peer-reviewed full reports will be included.
Condition/domain being studied
The main domain being investigated is IgE-mediated food allergy. We will explore any food allergen. Food
allergens will be ranked by the frequency of available studies and index test, with the most commonly
investigated allergen prioritised, if necessary. This is because we will assume that more studies will raise
more high-quality studies, thus firming evidence. Next, the more recently developed tests (CRD, BAT,
MAT) will be prioritised according to the frequency of reports. The previous EAACI Food Allergy Guideline
paper has already given recommendations for SPT and specific IgE, and we aim to summarise novel evidence
on SPT and specific IgE if this seems warranted.
Population
Studies of children and adults, irrespective of age, with suspected IgE-mediated allergy to any food will be
considered.
Interventions
Any index tests to diagnose food allergy in the included studies will be reported. Priority will be placed




























































































































The comparator to define the accuracy for immediate-type food allergy diagnosis will be OFC, including both
open food challenge or double-blind placebo-controlled food challenge, performed in at least a proportion of
study participants.
Inclusion criteria
Studies fulfilling the following criteria will be included:
Studies containing sufficient data to calculate sensitivity and specificity, to get a measure of the diagnostic
accuracy.
Diagnostic test studies with any sequence of index test and reference standard test performed and with
any algorithm or procedure of participant selection. These characteristics will be part of the risk of bias
assessment and evaluation of reasons for heterogeneity as laid out below.
Exclusion criteria
Studies fulfilling the following criteria will be excluded:
• Conference abstracts
• Narrative reviews, editorials and correspondence
• Systematic reviews (reference lists will first be scanned for relevant original articles)
• Qualitative studies
• Case reports and case series
• Animal studies
• Studies in which allergies are defined based on sensitization tests alone without a history following
ingestion.
• Studies may be excluded based on risk of bias and applicability
Each study will be screened by two reviewers independently based on the title and abstract according to the
inclusion and exclusion criteria (described below). If there are any discrepancies between the reviewers, a
third reviewer will adjudicate. When the studies have been selected, the full texts will be reviewed to confirm
they meet the inclusion criteria. Data will be extracted from these studies and the quality will be assessed
for risk of bias and applicability. Studies which satisfy the inclusion criteria but are not in English will be
translated prior to data extraction and quality assessment.
Data extraction and management
The details that will be collected from the selected studies are represented in Box 2 . Data extraction will be
conducted by two independent reviewers and subsequently recorded using COVIDENCE. Any discrepancies
will be resolved by a third reviewer.
Quality assessment (risk of bias)
All included studies will be assessed for risk of bias and their applicability based on the QUADAS 2
instrument12. The four key domains covering patient selection, index test, reference standard (compara-
tor), and flow and timing will be evaluated. Any studies deemed to have a high risk of bias i.e. scoring ‘high’
for three or more of the four risk of bias domains, or concerns regarding applicability i.e. scoring ‘high’ for
two or more of the three applicability domains will be excluded from further meta-analyses.
Strategy for data synthesis
When possible, data extracted for sensitivity and specificity will be analysed using random effects meta-
analysis using hierarchical summary receiver operating characteristic (ROC) curve analysis in case of three


























































































































The GRADE approach will be used to assess heterogeneity13,14, and will not solely rely on statistical methods
such as the I2 statistic. Depending on the included studies, the following reasons for heterogeneity will be
discussed:
• Multiple definitions of target condition
• Multiple thresholds of test positivity for index and/or comparator
• Age of the participants
• Origin of study population as indication for patient spectrum/pre-test probability
• All domains of risk of bias of the included studies
The GRADE approach will be used to evaluate the certainty of the body of evidence.
Sensitivity analysis
Sensitivity analysis may be carried out if three or more studies are retained for a given combination of
index test and food allergen following exclusion of studies which are suspected to contribute to heterogeneity
or limiting to studies with low risk of bias, i.e. studies with ‘low’ in all four risk of bias domains of the
QUADAS-2.
Dissemination plans
The final report will be published in one of the scientific journals affiliated with EAACI and will be used
to inform the update of the EAACI Guidelines on Food Allergy. The findings of the systematic review will
be presented at scientific conferences, namely the EAACI annual congress and at the EAACI Food Allergy
and Anaphylaxis Meeting. A summary of the findings will be made available in lay language on the EAACI
website.
Discussion
The EAACI Food Allergy Guidelines need to be updated, in particular the section on diagnostic tests for
food allergy. The systematic review of the literature on diagnostic tests that informed the current EAACI
Food Allergy Guidelines was conducted prior to 2014, thus a new systematic review is needed, especially
since emerging tests such as CRD, MAT and BAT were not included in the previous review. We report herein
the protocol for a systematic review of the literature, as registered at PROSPERO (CRD42021259186), and
provide a description of the rationale and methods chosen for the review.
OFC is the reference-standard diagnostic test for food allergies; however, there are considerable risks involved.
OFC involve ingesting the suspected allergen, which is associated with a risk of allergic reaction and may
result in a life-threatening event. As a result, OFC must be conducted in a controlled environment with
intensive care facilities in easy reach, and not all clinical settings can offer this service. Additionally, this risk
of reaction may lead to significant anxiety in patients and their families, therefore a reliable and cost-effective
alternative to OFC is needed. Since the previous guideline was published, newer tests such as CRD have
entered mainstream use in Europe and other regions. Also, studies assessing the efficacy of novel diagnostic
tests such as BAT and MAT have been published. All of these new tests must be reviewed to assess whether
they are acceptable diagnostic tools for use in routine clinical practice. For more established allergy tests, such
as SPT and sIgE, new studies have been performed since the previous review which may require updating of
the previous recommendation. We aim to evaluate the diagnostic test accuracy of any index test, from SPT,
sIgE to extracts, sIgE to individual allergens, sIgE to allergen peptides, BAT and MAT. Thus, we do not
include search terms for the index test. We apply a specific filter for diagnostic test accuracy studies, though,
which implicitly captures studies on diagnostics and/or tests. We only include search terms for “challenge”
as part of the common terminology for the comparator, i.e. oral food challenge, to have a sensitive search
regarding the comparator test.
The population of interest will include all ages and diverse clinical settings and geographical locations. We
deliberately do not include search terms to specify the target population and studies that do not have evidence


























































































































few if any diagnostic test accuracy studies conducted in animals; however, we will refrain from specifying
search terms that will exclude animal studies because of the risk of falsely excluding studies on animal
allergen sources. Certain food allergies are more prevalent in different areas. As such, we will include studies
focussing on any food, to be inclusive to all populations, although we anticipate that there will be more
studies on milk, egg and peanut allergies.
Although the gold standard is DBPCFC, we will also include studies where open oral food challenges are
performed and allow for the inclusion of studies where a small proportion of patients were diagnosed wi-
thout an oral food challenge due to previous severe or anaphylactic reactions. Studies focusing only on IgE
sensitisation will be excluded, as some patients who experience sensitisation to foods are not necessarily
allergic. It is important to note that the comparator reference standard test is oral food challenge and as
such, the systematic review will inform on the diagnostic accuracy of potential alternative tests. However,
the systematic review will not clarify which of these tests is best used in subjects in whom the oral food
challenge is contraindicated.
As outcomes we are assessing sensitivity and specificity as measures of diagnostic test accuracy. The positive
and negative predictive value of the test, which depends on the prevalence of the given food allergy in the
population, is not within the scope of this systematic review. The details collected as part of the quality
assessment and risk of bias will allow us to select high-quality studies at low risk of bias. The planned
sensitivity analyses on these features may help to identify factors that influence the performance of the test
and the modulation of the identified diagnostic cut-offs. If sufficient high quality studies are identified, the
planned meta-analyses will provide evidence which may help to reduce the number of patients that have to
undergo an OFC procedure.
Tables and Figures:
Box 1. Question central to the systematic review in the PICO format
Box 2. Data to be extracted from the full-length articles selected for the systematic review
Table 1. Search terms used in the systematic review.


























































































































1 “food hypersensit:”.mp OR “food
allerg:”.mp OR “food sensit:”.mp
OR “Food-dependent
exercise-induced anaphylaxis”.mp
OR “cow?? adj2 allerg:”.mp OR
“milk adj2 allerg:”.mp OR
“peanut? adj2 allerg:”.mp OR
“egg? adj2 allerg:”.mp OR “nut?
adj2 allerg:”.mp OR “hazelnut?
adj2 allerg:”.mp OR “walnut?
adj2 allerg:”.mp OR “pistachio?
adj2 allerg:”.mp OR “almond?
adj2 allerg:”.mp OR “brazil adj2
allerg:”.mp OR “macadamia adj2
allerg:”.mp OR “pecan adj2
allerg:”.mp OR “cashew? adj2
allerg:”.mp OR “sesame adj2
allerg:”.mp OR “soy? adj2
allerg:”.mp OR “lentil? adj2
allerg:”.mp OR “pea? adj2
allerg:”.mp OR “chickpea? adj2
allerg:”.mp OR “rice adj2
allerg:”.mp OR “celery adj2
allerg:”.mp OR “peach adj2
allerg:”.mp OR “apple? adj2
allerg:”.mp OR “wheat adj2
allerg:”.mp OR “gluten adj2
allerg:”.mp OR “mustard adj2
allerg:”.mp OR “meat adj3
allerg:”.mp OR “beef adj2
allerg:”.mp OR “pork adj2
allerg:”.mp OR “alpha-gal adj2
allerg:”.mp OR “fish adj2
allerg:”.mp OR “seafood adj2
allerg:”.mp OR “shrimp? adj2
allerg:”.mp
Clinical condition Most likely to
be captured by the first four
general search terms but
augmented by terms specific for
foods in combination with terms
for allergy in varying order (e.g.
“cashew allergy”, “cashew nut
allergy”, “allergic to cashew” will





broad term for reference
standard (i.e. oral food
challenge or provocation) or
anaphylaxis in instances when
oral challenges were not
conducted
3 sensitiv:.mp. OR “predictive
value:”.mp. OR accurac:.tw.
McMaster HiRU filter with best
balance of sensitivity and
specificity to identify diagnostic
test accuracy studies
4 1 AND 2 AND 3
5 MEDLINE: limit 3 to
dt=20121001-20210531
EMBASE: limit 3 to
dd=20121001-20210531
Date since end of the search
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